Commentary
This study by H. Ali et al. (Rutgers University New Jersey Medical School, USA) aims to explore outcomes in 429,855 patients who underwent percutaneous coronary intervention with or without placement of drug-eluting stents to determine whether the concurrent diagnosis of NAFLD led to worse in-hospital outcomes.
The authors conducted a cross-sectional study that included all adult patients who underwent PCI with or without placement of drug-eluting stents during hospital admission. Patients with NAFLD were identified and compared to patients without NAFLD.
There was no significant difference with regard to mortality and major adverse cardiac events.
Among patients who underwent PCI in 2016, those with NAFLD had a longer length of stay, were admitted at a younger age, and had significantly more cardiovascular comorbidities than those without NAFLD.
